-45.28 (-0.71%)
-13.70 (-2.90%)| 5-Day | 52,573 |
| 10-Day | 51,714 |
| 30-Day | 65,182 |
| 5-Day | 52,573 |
| 10-Day | 51,714 |
| 30-Day | 65,182 |
-12.60 (-2.67%)| 5-Day | 520,349 |
| 10-Day | 541,013 |
| 30-Day | 695,574 |
| 5-Day | 520,349 |
| 10-Day | 541,013 |
| 30-Day | 695,574 |
COLLAPSE ALL| Days | BSE | NSE |
| 30 | 435.07 | 435.32 |
| 50 | 443.22 | 443.32 |
| 150 | 455.14 | 455.42 |
| 200 | 449.30 | 449.58 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Lupin
| (Sep '11) Quarterly |
(Mar '11) Yearly |
|
| Net Sales | 1407.48 | 4508.50 |
| Other Income | 0.25 | 2.96 |
| PBDIT | 349.23 | 975.60 |
| Net Profit | 268.12 | 809.98 |
| Total Share Capital | 89.24 |
| Net Worth | 3152.66 |
| Total Debt | 983.29 |
| Net Block | 1354.63 |
| Investments | 680.88 |
| Net Current Assets | 1617.54 |
| Total Assets | 4135.95 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 541.30 | -0.12 | 565.75 | 404.00 | 56,056.05 |
| Cipla | 349.00 | -0.78 | 359.00 | 273.60 | 28,021.96 |
| Dr Reddys Labs | 1619.85 | -1.19 | 1716.00 | 1387.00 | 27,463.59 |
| Lupin | 458.80 | -2.90 | 492.00 | 363.00 | 20,491.02 |
| Ranbaxy Labs | 443.30 | -1.83 | 570.00 | 366.50 | 18,708.66 |
| More » | |||||
| Dec' 11 | Sep' 11 | Jun' 11 | Mar' 11 | |
| Promoter | 46.93 | 46.94 | 46.96 | 46.98 |
| FII | 26.21 | 26.14 | 23.57 | 21.97 |
| DII | 17.23 | 17.19 | 19.19 | 20.06 |
| Others | 9.63 | 9.73 | 10.28 | 10.99 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| Reliance Growth Fund - Retail Plan (G) | 5,156,845 |
| HDFC Top 200 Fund (G) | 3,369,409 |
| HDFC Equity Fund (G) | 2,459,436 |
| SBI Magnum Tax Gain Scheme (G) | 2,144,399 |
|
| Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
Bigg Boss Season 5
| History India | Davos
| Uninor | Aurobindo Pharma | Niko Resources | Vodafone Essar | Suzlon Energy | Etisalat | Tata Steel | National missile defense | Search Engines | Acropolis